These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 32710014)

  • 1. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.
    Kudelka MR; Stowell SR; Cummings RD; Neish AS
    Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):597-617. PubMed ID: 32710014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glycans in health and disease: Regulators of the interaction between gut microbiota and host immune system.
    Crouch LI; Rodrigues CS; Bakshani CR; Tavares-Gomes L; Gaifem J; Pinho SS
    Semin Immunol; 2024 May; 73():101891. PubMed ID: 39388764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
    Yu Y; Yang W; Li Y; Cong Y
    Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crosstalk between gut bacteria and host immunity in intestinal inflammation.
    Yang Q; Wang Y; Jia A; Wang Y; Bi Y; Liu G
    J Cell Physiol; 2021 Apr; 236(4):2239-2254. PubMed ID: 32853458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer.
    Jackson DN; Theiss AL
    Gut Microbes; 2020 May; 11(3):285-304. PubMed ID: 30913966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease.
    Fernández-Tomé S; Ortega Moreno L; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diet-Microbiota Interactions in Inflammatory Bowel Disease.
    Sugihara K; Kamada N
    Nutrients; 2021 May; 13(5):. PubMed ID: 34062869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
    Gasaly N; de Vos P; Hermoso MA
    Front Immunol; 2021; 12():658354. PubMed ID: 34122415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recipe for IBD: can we use food to control inflammatory bowel disease?
    Witkowski M; Witkowski M; Gagliani N; Huber S
    Semin Immunopathol; 2018 Feb; 40(2):145-156. PubMed ID: 29124320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues.
    Lee M; Chang EB
    Gastroenterology; 2021 Jan; 160(2):524-537. PubMed ID: 33253681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mucin
    Fekete E; Buret AG
    Am J Physiol Gastrointest Liver Physiol; 2023 Jun; 324(6):G452-G465. PubMed ID: 37070751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture.
    Sommer F; Adam N; Johansson ME; Xia L; Hansson GC; Bäckhed F
    PLoS One; 2014; 9(1):e85254. PubMed ID: 24416370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.
    Iyer N; Corr SC
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glycosylation in IBD.
    Theodoratou E; Campbell H; Ventham NT; Kolarich D; Pučić-Baković M; Zoldoš V; Fernandes D; Pemberton IK; Rudan I; Kennedy NA; Wuhrer M; Nimmo E; Annese V; McGovern DP; Satsangi J; Lauc G
    Nat Rev Gastroenterol Hepatol; 2014 Oct; 11(10):588-600. PubMed ID: 24912389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota and mucosal defense in IBD: an update.
    Stange EF; Schroeder BO
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):963-976. PubMed ID: 31603356
    [No Abstract]   [Full Text] [Related]  

  • 19. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
    Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
    Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.